Skip to main content

Skin Cancer

Skin Cancer

Featured

FDA Alerts
The FDA announced approval of cemiplimab-rwlc for basal cell carcinoma (BCC), giving dermatologists managing locally advanced and metastatic BCC now have another option in their toolbox.
Online Exclusive
Throughout his two presentations at the inaugural Skin Cancer Symposium, Joan Guitart, MD, FAAD, highlighted the most common forms of CTCL, mycosis fungoides.
Online Exclusive
Brent Moody, MD, FAAD, presented an overview of squamous cell carcinoma (SCC) and its treatment options at the inaugural Skin Cancer Symposium. His sessions shared a number of pearls to keep in mind w
Online Exclusive
At the inaugural Skin Cancer Symposium, Suzanne Olbricht, MD, FAAD, spoke about updates in treating BCC over two presentations. The first session focused on surgical treatment considerations and the s
News
A recent study argued its results could increase early detection of cutaneous squamous cell carcinoma through development of recommendations within actinic keratosis treatment.
Back to Top